Atul Varadhachary
Principal investigator, leads FANNIN PARTNERS LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$5.9MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $5.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 11, 2025 | NIH | SBIR Phase I Developing Scg3 Raptamers as a novel targeted therapy for wet AMD | $300K | FANNIN PARTNERS LLC |
| Aug 29, 2025 | NIH | SBIR Phase II Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia | $1000K | FANNIN PARTNERS LLC |
| Apr 19, 2024 | NIH | SBIR Phase I Investigation of a Novel PDE4B Inhibitor for Stimulant Use Disorder | $320K | FANNIN PARTNERS LLC |
| Sep 14, 2023 | NIH | SBIR Phase II Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia | $84K | FANNIN PARTNERS LLC |
| Apr 1, 2022 | NIH | SBIR Phase II Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia | $1.1M | FANNIN PARTNERS LLC |
| Mar 30, 2022 | NIH | SBIR Phase II Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia | $1000K | FANNIN PARTNERS LLC |
| Sep 13, 2019 | NIH | SBIR Phase I Artificial Urethral Sphincter for Control of Urinary Incontinence in Pediatric Patients | $225K | FANNIN PARTNERS LLC |
| Sep 13, 2019 | NIH | SBIR Phase I Artificial Urethral Sphincter for Control of Urinary Incontinence in Pediatric Patients | $225K | FANNIN PARTNERS LLC |
| Jul 22, 2019 | NIH | SBIR Phase II Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery | $999K | FANNIN PARTNERS LLC |
| Sep 21, 2017 | NIH | SBIR Phase I Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery | $225K | FANNIN PARTNERS LLC |
| Sep 21, 2017 | NIH | SBIR Phase I Uterine Wall Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery | $225K | FANNIN PARTNERS LLC |
| Aug 16, 2017 | NIH | SBIR Phase I Ureteral Stent Electromagnetic Removal (USER) Device for Pediatric Patients | $225K | FANNIN PARTNERS LLC |
Peer ranks
Federal funding#200
Awards as PI#86
Patents#273
Companies
- FANNIN PARTNERS LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.